Global Health Limited · NSE:MEDANTA
Global Health — Q1 FY2026 Earnings Presentation
31 slides from Global Health's earnings presentation, Aug 7, 2025
Slide 1: Cover letter to stock exchanges
August 07, 2025 Ref:- GHL/2025-26/EXCH/41 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 S
Slide 2: Investor Presentation Q1 FY2026
GLOBAL HEALTH LIMITED Dedicated to Life Investor Presentation Q1 FY2026 5 7th August, 2025 1
Slide 3: Disclaimer
Disclaimer This presentation, apart from historical information, contains some "forward-looking statements" including those describing the Company’s strategies, strategic direction, objectives, future prospects, estimates etc. These forward-looking statements involve a number of risks, uncertainties
Slide 4: Contents
Contents 01 Q1 FY2026 Performance Update 02 Project Update and Capex Plan 03 Medanta’s Journey, Purpose and Model of Healthcare 04 Annexures 3
Slide 5: Q1 FY2026 Performance Update
01 Q1 FY2026 Performance Update 4
Slide 6: Q1 FY2026 performance summary
Q1 FY2026 performance summary Highest ever quarterly Total Income and EBITDA reported in Q1 FY2026 Robust topline growth of 19% and EBITDA growth of 23%, led by increase in patient volumes and realization INR 10,513 million INR 2,553 million INR 1,590 million Total Income EBITDA1 and Margins % Margi
Slide 7: Q1 FY2026 performance summary
Q1 FY2026 performance summary Revenue growth of 19% y-o-y, primarily led by increase in patient volumes and realization Consolidated Total Income of INR 10,513 million, grew by 19.1% y-o-y. The growth was primarily driven by increase in patient volumes and improved realization EBITDA1 was INR 2,553
Slide 8: Q1 FY2026 Business Update
Q1 FY2026 Business Update Strengthening the core and building strong pipeline for growth Capacity Expansion New Medical Equipment Deployed in Q1 FY26 Machines added in Gurugram Patna: Total of 20 beds have been added on the 9th floor of Tower A, completing the tower Ranchi: Newly built 110 bedde
Slide 9: Medanta operationalized ~110 bedded newly built hospital in Ranchi
Medanta operationalized ~110 bedded newly built hospital in Ranchi Elevating healthcare in underserved markets Hospital Fact and Key Terms 1. Medanta Hospital, Ranchi Operationalized on 23rd July 2025 2. 8 Associate Consultant and above doctors hired for new unit 3. Immediate Priorities: • Formal in
Slide 10: Key operating metrics: Revenue and profitability
Key operating metrics: Revenue and profitability Strong year on year and sequential growth across key metrics Total Income (INR million) EBITDA (INR million and margin %) +19.1% +22.6% 10,513 9,542 2,476 2,553 8,830 +10.2% 3.0% 2,082 Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26 23.6% 26.0% 24.3%
Slide 11: Key operating metrics: Volumes, occupancies, ALOS
Key operating metrics: Volumes, occupancies, ALOS Occupied bed days grew by 13%, driven by in-patient volume growth of 14% y-o-y, occupancy at 63% in Q1 FY26 Average census and occupied beds ALOS (days) +13.4% -0.7% +5.6% 3.05 3.19 3.03 2,354 2,480 2,487 1,385 1,518 1,571 Q1 FY25 Q4 FY25 Q1 FY26 Q1
Slide 12: Key operating metrics: ARPOB and revenue mix
Key operating metrics: ARPOB and revenue mix ARPOB growth driven change in specialty mix; cancer contribution is increasing ARPOB* (INR) IPD Revenue mix by payor category +4.0% 64,035 63,629 66,584 57% 57% 55% 26% 25% 27% 4% 4% 4% 10% 4% 10% 4% 11% 3% Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26
Slide 13: Diverse revenue mix
Diverse revenue1 mix Significant contribution from complex specialties. Cancer contribution is increasing Heart 23.0% 22.2% 21.2% Cancer 13.7% 14.6% 14.4% Digestive 11.6% 11.4% 11.3% Neuro 10.9% 11.5% 11.4% Kidney & Urology 7.6% 7.3% 7.4% Internal Medicine 5.3% 5.1% 5.1% Ortho 5.1% 5.0% 5.9% 3.8% 3.
Slide 14: Growth seen in both mature and new hospitals
Growth seen in both mature and new hospitals Developing hospitals delivered robust revenue and EBITDA y-o-y growth Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million and
Slide 15: Project Update and Capex Plan
02 Project Update and Capex Plan 14
Slide 16: Noida hospital construction update
Noida hospital construction update Medanta Noida to commence operations in Q2 FY26 • Project situated in sector 50 Noida, close proximity to metro station • Bed capacity of 550 beds and expected to commence operations with 300 beds in Q2 FY26 • Designed for delivering highest level of patient care,
Slide 17: On-going expansion project update
On-going expansion project update Planned bed capacity addition; well positioned to drive near term growth Number of installed beds ~2,000 bed addition +50.2% 400 ~1,000 bed addition 750 ~219 bed addition +34.2% 400 500 +7.8% 100 60 250 300 100 100 2,823 112 20 110 6,132 49 58 3,042 4,082 31-Mar-24G
Slide 18: Capex plan next 5 years
Capex plan next 5 years Total capex of over ~Rs. 40,000 million planned for next 5 years for ~3,000 bed addition 2,489 3,000 5,100 5,864 39,574 10,550 34,085 2,997 4,273 4,500 649 152 Maintenance Ranchi Lucknow Noida South Mumbai Pitampura, Guwahati Medical Guest Total Capex for 3 New and Patna Delh
Slide 19: Medanta's Journey, Purpose and Model of Healthcare
Medanta’s Journey, Purpose and 03 Model of Healthcare 18
Slide 20: Medanta was founded to bring a new type of healthcare to India
Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec
Slide 21: Growth from a single flagship hospital in Gurgaon
Growth from a single flagship hospital in Gurgaon… …to a network of 5 high quality hospitals across north India 2026E MEDANTA 2025 HOSPITAL MEDANTA NOIDA 2021 HOSPITAL Plan for 550 beds JAI PRABHA Ranchi** Expected to 2019 MEDANTA SPECIALTY begin phase I 110 Beds MEDANTA HOSPITAL operations with Com
Slide 22: From our flagship Medicity campus, we have grown to ~3,062 beds
From our flagship Medicity campus in Gurgaon, we have grown to ~3,062 beds across 5 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar Gurgaon LUCKNOW PATNA 1,440 beds; 316 ICU beds 757 beds; 202 ICU beds (950 planned) 490 beds; 147 ICU beds (650
Slide 23: One of the largest private hospital chains in North and East India
One of the largest private hospital chains in North and East India Serving over 400 million people in the States with Medanta facilities Gurugram; Largest single location private hospital in with operational Delhi; ~1,150 bed addition bed capacity of 1,440 Our Network planned with 750 beds in Pitamp
Slide 24: Our Mission and Values
Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla
Slide 25: The Medanta Model of Healthcare
The Medanta Model of Healthcare Delivering the highest quality of medicine with care and compassion Exceptional clinical talent What it means for patients and caregivers? • Super specialized doctors provide the highest quality of care through a team based integrated approach Trust based compassionat
Slide 26: Medanta is well placed to deliver sustainable growth
Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro
Slide 27: Annexures
04 Annexures 26
Slide 28: Annexure: Profit and Loss Statement
Annexure: Profit and Loss Statement Quarter INR million Q1 FY25 Q4 FY25 Q1 FY26 Y-o-Y Growth % Revenue from operations 8,611 9,312 10,308 19.7% Other income 219 229 205 (6.7)% Total income 8,830 9,542 10,513 19.1% Cost of materials consumed 2,089 2,136 2,391 14.5% Employee benefits expense 3,197 3,3
Slide 29: Annexure: Operational Parameters
Annexure: Operational Parameters Quarter Key metrics Q1 FY25 Q4 FY25 Q1 FY26 Y-o-Y Growth % Total Beds 2,890 3,042 3,062 6.0% Census Beds 2,354 2,480 2,487 5.7% Occupied Bed Days 126,072 136,761 142,898 13.3% Occupancy Rate % 58.8% 61.2% 63.2% 399 bps ARPOB (INR)* 64,035 63,629 66,584 4.0% ALOS (day
Slide 30: Annexure: Abbreviations and Definitions
Annexure: Abbreviations and Definitions Abbreviations INR : Indian Rupee NABH : National Accreditation Board for Hospitals & Healthcare Providers NABL : National Accreditation Board for Testing and Calibration Laboratories JCI : Joint Commission International OPD : Out-Patient Department
Slide 31: Contact us
Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a